VIGL

Vigil Neuroscience, Inc.

3.86 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vigil Neuroscience, Inc. stock is up 6.34% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 June’s closed higher than May.

About Vigil Neuroscience, Inc.

Vigil Neuroscience, Inc. engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) The company also develops a small molecule TREM2 agonist suitable for oral delivery.